What is NDC 0409-0032?

0409-0032 is the product NDC for Potassium Phosphates, Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL injection, solution, concentrate, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Monobasic potassium phosphate, Dibasic potassium phosphate.

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Phosphates?

24 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Phosphates NDC 0409-0032 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-0032Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-0032Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-0032-01	00409003201	25 VIAL, SINGLE-DOSE in 1 TRAY (0409-0032-01) / 15 mL in 1 VIAL, SINGLE-DOSE (0409-0032-10)Marketed from Sep 29, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Phosphates
Generic name (nonproprietary): potassium phosphates
Active ingredients: Monobasic potassium phosphate — 224 mg/mLDibasic potassium phosphate — 236 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217459
Marketing start: Sep 29, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
Identifiers: Product ID 0409-0032_bc88fab4-5971-468e-b2e0-907a4d91899dSPL ID bc88fab4-5971-468e-b2e0-907a4d91899dSPL set ID 2fcbc814-c7a4-469a-8b1d-6819b961bfb9RxCUI 1928569UNII 4J9FJ0HL51, CI71S98N1Z
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409003201 followed by a unit qualifier and the quantity

Package 00409-0032-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2025.

Indications (excerpt from the label)

Potassium Phosphates Injection is indicated as a source of phosphorus: • in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. • for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. Potassium Phosphates Injection is a phosphorus replacement product indicated as a source of phosphorus: • in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. ( 1 ) • for parenteral nutrition in adults and p…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-0032

What is NDC 0409-0032?: 0409-0032 is the product NDC for Potassium Phosphates, Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL injection, solution, concentrate, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Phosphates.
What is the active ingredient?: Monobasic potassium phosphate, Dibasic potassium phosphate.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Phosphates?: 24 other product NDCs are listed under this name. See all Potassium Phosphates NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Phosphates NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-194	65145-0194-25
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-195	65145-0195-25
Potassium Phosphates	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Caplin Steriles Limited	65145-196	65145-0196-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-786	68462-0786-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-787	68462-0787-25
Potassium Phosphates	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-788	68462-0788-25
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic injection,	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Solution, ConcentrateIntravenous	Amneal Pharmaceuticals Private Limited	80830-1691	80830-1691-07
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic injection,	Potassium phosphate, Monobasic 224 mg/mL; Potassium phosphate, Dibasic 236 mg/mL	Solution, ConcentrateIntravenous	Amneal Pharmaceuticals Private Limited	80830-1691	80830-1691-09
Potassium Phosphates	Monobasic potassium phosphate 11.2 mg/mL; Dibasic potassium phosphate 11.8 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-656	65219-0656-10
Potassium Phosphates	Monobasic potassium phosphate 4.48 mg/mL; Dibasic potassium phosphate 4.72 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-658	65219-0658-25

All 25 Potassium Phosphates NDCs